// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Diagnosing sleep disorders: a continued argument for overnight oximetry

Javed Ibrahim - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Skin integrity in domiciliary non-invasive ventilation: a clinical audit

Sarah Ewles - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The impact of chronic non-specific cough on children and their families

Gill Waring - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changes in cognitive function of cognitively impaired patients with COPD after Pulmonary Rehabilitation and 1-year follow-up

Vasileios Andrianopoulos - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The acute effect of inhaled salbutamol and ipratropium on microvascular function

Kashyap Chauhan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ipratropium

Cost-effectiveness of a single inhaler triple therapy versus ICS/LABA in COPD

Alan A Martin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Using DPM CT analysis to assess the contribution of small airways disease in COPD

Kristoffer Ostridge - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension

David Kiely - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Responsiveness of a short stair climb power test to pulmonary rehabilitation in COPD

Sarah Jones - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Identifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI)

Vincent Cottin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

N/A

Late Breaking Abstract - Dietary nitrate supplementation increases exercise endurance time in COPD patients using ambulatory oxygen

Matthew Pavitt - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

A multidisciplinary approach to post intensive care tracheostomy weaning and the impact of a dedicated team on decannulation rates and outcome in a regional UK major trauma centre

Rachael Moses - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

N/A

Evaluation of clinical and operational outcomes of a Point of Care Test for patients with suspected influenza in an acute medical unit.

Anuradha Jayachandran - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Influenza

N/A

Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Heba Nashat - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

macitentan

Dupilumab shows rapid and sustained suppression of inflammatory biomarkers in asthma patients in LIBERTY ASTHMA QUEST

Sally Wenzel - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Dupilumab

Cardiopulmonary exercise test provides valuable information on function and prognosis in PAH

Rocco Francesco Rinaldo - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Pulmonary arterial hypertension

N/A

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Wentao Chen - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Prostaglandin

Late Breaking Abstract - Multidimensional genomic mapping reveals the pathophysiology of Mycobacterium abscessus

Lucas Boeck - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

Biaxin

A retrospective clinical review of drug induced interstitial lung disease at a tertiary cancer centre

Fiona Walker - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Interstitial lung disease

N/A

Acute lung injury induced by intestinal ischemia and reperfusion is altered in obese female mice

Yanira Riffo-Vasquez - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute lung injury

N/A

Copyright © 2026. QuantiNova All rights reserved